Jayasuriya Anula 4
4 · Lineage Cell Therapeutics, Inc. · Filed May 6, 2021
Insider Transaction Report
Form 4
Jayasuriya Anula
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-04+90,000→ 90,000 totalExercise: $2.58Exp: 2031-05-03→ Common Shares (90,000 underlying)
Footnotes (1)
- [F1]This option vests in 36 monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continuous service on the board of directors of the issuer.